Human cytomegalovirus latency and reactivation -: A delicate balance between the virus and its host's immune system

被引:81
作者
Söderberg-Nauclér, C [1 ]
Nelson, JA
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[2] Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA
关键词
cytomegalovirus; macrophages; latency; reactivation; allogeneic stimulation;
D O I
10.1159/000053966
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that still causes severe morbidity and mortality in immunocompromised individuals. During its evolution, the virus has developed sophisticated methods to evade immune recognition and to establish life-long persistence in its host. Today, we know that the virus establishes latency in myeloid lineage cells and that the virus is dependent on immune activation mechanisms to reactivate it from latency to produce a new viral progeny, During this process, a number of viral proteins are produced that interfere with different immune recognition pathways. The current knowledge of the delicate balance between the virus' continuous existence and its host's immune system will be summarized in this chapter, Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 81 条
[1]  
[Anonymous], TRANSPLANT INT
[2]   The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection [J].
Beisser, PS ;
Vink, C ;
Van Dam, JG ;
Grauls, G ;
Vanherle, SJV ;
Bruggeman, CA .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2352-2363
[3]  
BOSTROM L, 1990, BONE MARROW TRANSPL, V5, P321
[4]   TRANSFUSION-TRANSMITTED CYTOMEGALOVIRUS-INFECTION [J].
BOWDEN, RA .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1995, 9 (01) :155-&
[5]  
BRITT WJ, 1996, FIELDS VIROLOGY, P2493
[6]   Viral inhibition of interferon signal transduction [J].
Cebulla, CM ;
Miller, DM ;
Sedmak, DD .
INTERVIROLOGY, 1999, 42 (5-6) :325-330
[7]   ACQUISITION OF DONOR STRAINS OF CYTOMEGALOVIRUS BY RENAL-TRANSPLANT RECIPIENTS [J].
CHOU, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (22) :1418-1423
[8]   INFECTIOUS-DISEASES SOCIETY OF AMERICA AND CENTERS FOR DISEASE-CONTROL - SUMMARY OF A WORKSHOP ON SURVEILLANCE FOR CONGENITAL CYTOMEGALOVIRUS DISEASE [J].
DEMMLER, GJ .
REVIEWS OF INFECTIOUS DISEASES, 1991, 13 (02) :315-329
[9]  
DUNCOMBE AS, 1990, BLOOD, V76, P1046
[10]   REDUCED MORTALITY IN MURINE CYTOMEGALO-VIRUS INFECTED MICE FOLLOWING PROPHYLACTIC MURINE INTERFERON-GAMMA TREATMENT [J].
FENNIE, EH ;
LIE, YS ;
LOW, MAL ;
GRIBLING, P ;
ANDERSON, KP .
ANTIVIRAL RESEARCH, 1988, 10 (1-3) :27-39